XyberCyl is a hernia repair solution designed to be complication-free, fostering natural tissue growth and enabling the abdominal wall to heal itself with a long-term resolution.
- General Details
XyberCyl presents a revolutionary approach to ventral hernia repair with its advanced surgical mesh device. This innovative product features a monofilament silicone material designed with patented wide-open spaces. Unlike traditional surgical meshes that often lead to complications, XyberCyl’s design aims to prevent irritation and foreign body reactions, ensuring a complication-free experience. By harnessing the body’s natural healing capabilities within its environment, XyberCyl facilitates robust healing and offers a permanent solution to ventral hernia defects.
Key Features of XyberCyl Surgical Mesh Device
- Prevention of Complications
XyberCyl minimizes the risk of post-surgery complications commonly associated with traditional meshes. Its monofilament silicone material and wide-open spaces reduce the likelihood of irritation and foreign body reactions. This innovative design ensures a smoother recovery process for patients. - Harnessing Natural Healing
The XyberCyl surgical mesh device supports the body’s natural healing processes. By providing a stable yet biologically invisible mechanical support, it stabilizes the abdominal wall without triggering adverse reactions. This capability allows for physiological and lasting hernia repair. - Permanent Solution
XyberCyl offers a permanent solution to ventral hernia defects. Unlike temporary fixes, this surgical mesh device integrates seamlessly with the body’s tissues, providing long-term stability and support. Patients benefit from a durable repair that addresses the root cause of hernias.
Benefits of XyberCyl Surgical Mesh Device
- Enhanced Patient Well-Being
Patients experience fewer complications and a smoother recovery process with XyberCyl. The reduction in foreign body reactions and irritation leads to improved overall well-being. Patients can return to their daily activities faster and with less discomfort. - Improved Surgical Outcomes
Surgeons can achieve better outcomes using the XyberCyl surgical mesh device. Its design promotes natural healing and reduces the risk of complications, resulting in higher success rates for hernia repairs. The device’s effectiveness enhances the reputation of surgical practices. - Cost-Effective Solution
By minimizing complications and the need for follow-up surgeries, XyberCyl proves to be a cost-effective solution for ventral hernia repair. Hospitals and healthcare providers can reduce overall treatment costs while providing high-quality care to patients.
XyberCyl represents a significant advancement in the field of surgical mesh devices for ventral hernia repair. Its innovative design, which prevents complications and promotes natural healing, sets it apart from traditional meshes. By offering a permanent solution that enhances patient well-being and improves surgical outcomes, XyberCyl establishes itself as a leading choice for hernia repair. Surgeons and healthcare providers can trust XyberCyl to deliver reliable, long-lasting results that benefit both patients and medical practices.
If you are interested in Xybercyl, please visit this link.
- Prevention of Complications
- Patent Portfolio
The IP and assets available for sale include:
- Patent No. US-10792142-B2 – Entitled “Implantable areal device for supporting tissue”
- Publication No. US20180168791A1 – Entitled “Implantable areal device for supporting tissue”
- Publication No. US-20210204981-A1 – Entitled “Implantable Tissue Stabilizing Structure for in situ Muscle Regeneration”
- Publication No. US20200069844A1 – Entitled “Implantable Tissue Stabilizing Structure for in situ Muscle Regeneration”
- Publication No. US20200069408A1 – Entitled “Implantable Tissue Stabilizing Structure for in situ Muscle Regeneration”
- Patent No. EP2819616B1 – Entitled “Tissue Support Structure”
- Publication No. EP3705086-A1 – Entitled “Implantable Tissue Stabilizing Structure for in Situ Muscle Regeneration”
- Data Room Access & Additional Details
Other Publicly Data Room Materials Are Available at: Link to VIP-3297 Public Data Room
- Introductory Material
- Patents and Patent Applications
- Patent File Histories
- Additional Information Regarding Ventral Hernia and Related Products
- Non-Disclosure Agreement Draft to access more files listed below
Additional Materials (available upon signing mutual non-disclosure agreement):
- Due Diligence Review
- Patent Assignments and Ownership
- The Conception and Development of XyberCyl
- Presentations and Clinical Trials
- Market Data
- Benefits of XyberCyl
- Proof of concept and working prototypes may be available.
This intellectual property may be of interest to companies similar to the following:
· Healionics · Medtronics · Viscus Biologics · Allergan · Johnson & Johnson · Becton, Dickinson and Company (BD) · Sanofi SA · Atrium Medical · B. Braun Melsungen · Gore Medical · Evonik · Tela Bio · 3M · Boston Scientific - Media
- More Information
Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Spencer Rogers at Vibrant IP, LLC at spencer@vibrantip.com and 415-997-9772.
